---
title: "NET-A-GO TECH released its annual performance report, with a loss attributable to shareholders of HKD 90.28 million, an increase of 293.19% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281085303.md"
description: "NET-A-GO TECH released its 2025 annual performance, with group revenue of HKD 289 million, a year-on-year decrease of 1.98%; shareholders' attributable loss of HKD 90.28 million, a year-on-year increase of 293.19%; loss per share of HKD 0.12. The gross loss was approximately HKD 220 million, mainly due to impairment losses resulting from the termination of advertising distribution rights-related contracts"
datetime: "2026-03-30T22:48:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281085303.md)
  - [en](https://longbridge.com/en/news/281085303.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281085303.md)
---

# NET-A-GO TECH released its annual performance report, with a loss attributable to shareholders of HKD 90.28 million, an increase of 293.19% year-on-year

According to the Zhitong Finance APP, NET-A-GO TECH (01483) released its performance for the fiscal year 2025, reporting group revenue of HKD 289 million, a year-on-year decrease of 1.98%; a loss attributable to shareholders of HKD 90.28 million, a year-on-year increase of 293.19%; and a loss per share of HKD 0.12.

The announcement stated that the gross loss for the year was approximately HKD 220 million (last year: gross profit of approximately HKD 115 million), primarily due to impairment losses from the termination of relevant distribution contracts for advertising distribution rights this year

### Related Stocks

- [01483.HK](https://longbridge.com/en/quote/01483.HK.md)

## Related News & Research

- [Marketers, it's okay to let creators get experimental with your ads](https://longbridge.com/en/news/290586963.md)
- [From collection to confidence: why clinical trial data reliability starts early](https://longbridge.com/en/news/290588706.md)
- [Post-marketing oncology studies: Enabling faster recruitment and lower costs](https://longbridge.com/en/news/290423986.md)
- [11:11 ETTiger Pistol Releases Updated Edition of The Ultimate Vertical Video Advertising Playbook](https://longbridge.com/en/news/290584726.md)
- [First participant receives Evategrel in CureGene’s trial](https://longbridge.com/en/news/290454621.md)